Results 1 to 10 of about 13,620 (172)

Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine development [PDF]

open access: yesNature Communications
Enveloped viruses are significant zoonotic disease threats with the potential to cause global pandemics. We identified a class of small-molecule sulfur-containing antiviral compounds (XM series) that broadly inhibit enveloped viruses.
David W. Buchholz   +40 more
doaj   +2 more sources

A replicating recombinant vesicular stomatitis virus model for dairy cattle H5N1 influenza virus glycoprotein evolution [PDF]

open access: yesJournal of Virology
A panzootic of highly pathogenic avian influenza (HPAI) H5N1 viruses from clade 2.3.4.4b has triggered a multistate outbreak in US dairy cattle and an unknown number of human infections.
Lindsey R. Robinson-McCarthy   +4 more
doaj   +2 more sources

N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages [PDF]

open access: yesJournal of Virology
Receptor specificity plays a critical role in influenza virus host tropism and pathogenesis. Influenza A and influenza B viruses (FLUAVs and FLUBVs, respectively) utilize N-glycans with terminal sialic acids on glycoproteins decorating the surface of ...
Caroline K. Page   +11 more
doaj   +2 more sources

Unsupervised classification of influenza virus surface spikes from cryo-EM reconstructions using head-to-stem width ratio [PDF]

open access: yesVirology Journal
Accurate identification of influenza virus surface glycoproteins—hemagglutinin (HA) and neuraminidase (NA)—is critical for understanding viral morphology and supporting vaccine development.
Younes Benkarroum
doaj   +2 more sources

Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics

open access: yesmBio, 2021
Since its emergence in 2009, the pandemic H1N1 influenza A virus (IAV) has caused significant disease and mortality in humans. IAVs contain two envelope glycoproteins, the receptor-binding hemagglutinin (HA) and the receptor-destroying neuraminidase (NA).
Meiling Dai   +10 more
doaj   +1 more source

B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

open access: yesViruses, 2021
Antibodies are critical for providing protection against influenza virus infections. However, protective humoral immunity against influenza viruses is limited by the antigenic drift and shift of the major surface glycoproteins, hemagglutinin and ...
Jenna J. Guthmiller   +2 more
doaj   +1 more source

Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time. [PDF]

open access: yesPLoS Pathogens, 2012
The influenza virus uses the hemagglutinin (HA) and neuraminidase (NA) glycoproteins to interact with and infect host cells. While biochemical and microscopic methods allow examination of the early steps in flu infection, the genesis of progeny virions ...
Maximilian Wei-Lin Popp   +2 more
doaj   +1 more source

Antiviral Activities of Ethyl Pheophorbides a and b Isolated from Aster pseudoglehnii against Influenza Viruses

open access: yesMolecules, 2022
Screening of the antiviral and virucidal activities of ethanol extracts from plants endemic to the Republic of Korea revealed the inhibitory activity of a 70% ethanol extract of the whole plant of A. pseudoglehnii (APE) against influenza virus infection.
Subin Park   +4 more
doaj   +1 more source

Adaptation of the H7N2 Feline Influenza Virus to Human Respiratory Cell Culture

open access: yesViruses, 2022
During 2016–2017, the H7N2 feline influenza virus infected more than 500 cats in animal shelters in New York, USA. A veterinarian who had treated the cats became infected with this feline virus and showed mild respiratory symptoms. This suggests that the
Wataru Sekine   +6 more
doaj   +1 more source

Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection. [PDF]

open access: yesPLoS ONE, 2013
Influenza vaccines that target the highly variable surface glycoproteins hemagglutinin and neuraminidase cause inconvenience of having vaccination every year.
So-Hee Kim   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy